Akebia Therapeutics (AKBA)

$1.37 0.07 (5.38%)

16:00 EDT AKBA Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Mar 15, 2024

It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!

AKBA Stock Earnings: Akebia Therapeutics Beats Revenue for Q4 2023

Pocket Change, Big Gains: 3 Penny Stocks Ready to Boom

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Volume:

Previous Close -

Market Cap 239.12M

PE Ratio -4.72

EPS -0.29

Volume (Avg. Vol.) 3.12M

Day's Range $1.32 - $1.42

52-Week Range $0.78 - $2.48

Dividend & Yield N/A (N/A)

AKBA Stock Predictions, Articles, and Akebia Therapeutics News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Feb 15, 2023

We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for trader need to know about Wednesday!

Why Is Akebia Therapeutics (AKBA) Stock Up 14% Today?

By William White, InvestorPlace Writer Jul 1, 2022

Akebia Therapeutics (AKBA) stock is taking off on Friday after the kidney treatment company revealed the return of rights for vadadustat.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jul 1, 2022

Good morning, trader! It's time for another look at the biggest pre-market stock movers as we dive into the latest news for Friday!

Akebia Therapeutics (AKBA) Stock Soars 18% Despite Lack of News

By Josh Enomoto, InvestorPlace Contributor Jun 29, 2022

AKBA stock is up big, but the lack of news is concerning considering that Akebia Therapeutics already faces a regulatory setback.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Jun 29, 2022

Good morning, trader! With the start of another day comes our breakdown of the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jun 15, 2022

It's time for another breakdown of the biggest pre-market stock movers as we get ready for the opening bell on Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer May 16, 2022

Welcome back and get ready for another busy week of trading as we start it off with the biggest pre-market stock movers for Monday!

7 Biotech Stocks With Key Catalysts in March

By Shanthi Rexaline Mar 9, 2022

These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways.

7 Speculative Penny Stocks Worth a Roll of the Dice

By Josh Enomoto, InvestorPlace Contributor Feb 25, 2022

Under any circumstance, penny stocks are extremely risky. However, their under-the-radar profile could be intriguing right now.

7 Small-Cap Stocks to Buy From the Beat-Up Bargain Bin

By Chris Lau, InvestorPlace Contributor Oct 11, 2021

Unwilling to wait for catalysts, some investors threw these small-cap stocks into the garbage bin. But that doesn't mean they won't succeed.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jun 1, 2021

Welcome back from the holiday weekend and let's get right into it with a look at the biggest pre-market stock movers for Tuesday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Apr 29, 2021

Good morning! We're getting ready for another day of trading with a list of the top pre-market stock movers for Thursday.

5 “Strong Buy” Biotech Stocks With More Than 80% Upside

By Maya Sasson, Writer, TipRanks Nov 27, 2019

For investors seeking out the ultimate high-risk, high-reward stocks, look no further than the biotech industry.

5 Healthcare Stocks That Are Down, But Not Out!

By Josh Enomoto, InvestorPlace Contributor Aug 29, 2018

Tough headwinds have impacted several healthcare stocks, presenting opportunities for risk-tolerant speculators.

Akebia Therapeutics Inc (AKBA) and Babcock & Wilcox Enterprises Inc (BW) Lead 18 Investor Reports

By Fintel May 23, 2017

13D and 13G filings are windows into activist investor activities. We look at 18 notable filings....

Akebia Therapeutics Surges on FDA Approval for Anemia Treatment

From MarketBeat Apr 3, 2024

Akebia Therapeutics Inc. (NASDAQ: AKBA) is a biopharmaceutical company specializing in developing treatments for chronic kidney diseases (CKD) and anemia

Akebia Therapeutics closes up to $500M loan facility (NASDAQ:AKBA)

From Seeking Alpha Jan 30, 2024

Akebia Therapeutics closed a $500M loan facility from BlackRock, allowing the biopharmaceutical company to borrow in three tranches.

Akebia stock gains as H.C. Wainwright upgrades (NASDAQ:AKBA)

From Seeking Alpha Aug 28, 2023

Akebia Therapeutics (AKBA) shares rose on Monday after H.C. Wainwright upgraded it, expecting FDA nod for its kidney disease candidate, vadadustat. Read more here.

Akebia to resubmit FDA application for kidney drug by end of Q3 (AKBA)

From Seeking Alpha Jul 18, 2023

Akebia Therapeutics (AKBA) said it plans to resubmit its market application to the FDA by the end of Q3 for its kidney disease drug vadadustat. Read more here.

Why Shares of Akebia Therapeutics Were Up Tuesday

From The Motley Fool May 23, 2023

An approval in the U.K. for Akebia's symptomatic anemia therapy boosted the stock.

H.C. Wainwright Keeps Their Hold Rating on Akebia Therapeutics (AKBA)

From TipRanks Nov 4, 2022

H.C. Wainwright analyst Ed Arce maintained a Hold rating on Akebia Therapeutics (AKBA – Research Report) today and set a price target of $1.25. The company&#8...

Akebia Therapeutics (AKBA)

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

AKBA Stock Earnings: Akebia Therapeutics Beats Revenue for Q4 2023

Pocket Change, Big Gains: 3 Penny Stocks Ready to Boom

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Akebia Therapeutics (AKBA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AKBA Stock Predictions, Articles, and Akebia Therapeutics News

Subscriber Sign in